Document Classification

Section Type: RESULTS

Text: Desmopressin compared with placebo significantly decreased the risk of postbiopsy bleeding (11 of 80 [13. 7 %] vs 25 of 82 [30. 5 %] ; relative risk, 0. 45 ; 95 % CI, 0. 24-0. 85 ; P = 0. 01), hematoma size (median, 208 [25th-75th percentile, 120-300] vs 380 [25th-75th percentile, 270-570] mm (2) ; P = 0. 006] in the 36 patients who experienced bleeding, and mean hospital stay (4. 9 1. 1 vs 5. 9 1. 7 days ; P = 0. 004) ; postbiopsy hemoglobin levels were not affected significantly in either group.